Who funds nanomedicine research?

We count 43 funded nanomedicine projects, active between 2021 and 2031, from 4 funders. The most came from EU · MSCA (18 projects), EU · ERC (13 projects) and EU · EIC (4 projects). The median award is $1.5M, across the 42 of 43 projects that list an amount.

Funded projects

43

Funders

4

Median award

$1.5M

Open calls now

1

Top funders of nanomedicine research

Projects whose title or summary mentions nanomedicine. Median award: of the projects that list an amount, in US dollars; “—” when fewer than 3 do.

Open nanomedicine funding calls

1 open call mentions nanomedicine today.

• Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)
  National Institutes of HealthNot specifiedDeadline: November 15, 2027 ·
  Real odds: About 1 in 8 funded (13% · NIH R01-equivalent grants, all NIH institutes, FY2025)

Real odds

• About 1 in 8 funded · 13% · NIH R01-equivalent grants, all NIH institutes, FY2025 · NIH Data Book, report 29

Published success rates for the programs behind the open calls above: the share of applications the funder funded, program-wide, not for this topic.

Funded nanomedicine projects

A sample, latest start first, at most three per program.

• Collaborative Research: Predictive Modeling of Coupled Nanoparticle-Membrane Mechanics as Determinants of Endocytic Pathways
  NSF · ENG · $298,403 · ends 2029
• Translational nanoconstructs for targeted tissue accumulation and guided surgery in cancer
  UKRI · EPSRC · £351,184 · ends 2027
• Development of mitochondria-targeted nanomedicines for cardiovascular applications
  Wellcome · £286,935 · ends 2027
• I-Corps: Translation Potential of an Ultrasound-Triggered Drug Delivery to the Brain
  NSF · TIP · $50,000 · ends 2027
• I-Corps: Translation potential of mRNA lipid nanoparticles to inhibit tumor DNA damage tolerance
  NSF · TIP · $50,000 · ends 2027
• AF4-MIP: Advancing AF4 for Precision Characterisation of Molecularly Imprinted Polymer Nanoparticles
  UKRI · EPSRC · £254,397 · ends 2027
• Capitalizing on apolipoprotein trafficking to deliver mRNA to the brain
  EU · MSCA · ends 2027
• Reconfigurable Colloids For Therapeutic Applications
  EU · MSCA · €4,635,442 · 2027–2031 · UNIVERSITAT POLITECNICA DE VALENCIA
• Tailored lipid nanoparticles for iontophoretic ocular drug delivery.
  EU · MSCA · €193,643 · 2027–2029 · UNIVERSITA DEGLI STUDI DI PARMA
• Advancing NANOmedicines to rewire tumoral MYeloid cells for next-generation cancer immunotherapies
  EU · ERC · €2,499,750 · 2026–2031 · UNIVERSITEIT GENT

How we count

Funded projects come from public award records (NIH RePORTER, NSF, EU CORDIS, UKRI Gateway to Research, Wellcome, the Gates Foundation, DOE, NASA and USDA NIFA) whose title or summary matches “nanomedicine or nanoparticle drug”. NIH lists each budget year separately; one project counts once. Amounts are as the funder lists them; medians use only projects that list one, in US dollars. Open calls and forecasts are from our listings of October 28, 2026. A project can mention a topic without being mainly about it, so treat the counts as a guide to who funds the area.